Shoulder Innovations, Inc. (SI) AI Stock Analysis

• Market Cap: $224.98M
• Dividend Yield: N/A
• Average Volume (3M): 130.13K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.28
• Revenue Growth: 39.77%
• EPS Growth: -122.70%
• Country: US
• Employees: 300
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Specialties
• EPS (TTM): N/A
• Shares Outstanding: 20,359,960
• 10 Day Avg. Volume: 53,279
• 30 Day Avg. Volume: 130,135
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.05
• Price to Sales (P/S): 0.03
• P/FCF Ratio: -0.05
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $18.57
• Price Target Upside: 68.05% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 5
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: $11.50 ▲(4.07% Upside)

The overall stock score of 41 reflects significant financial challenges, including negative earnings and cash flow issues, compounded by bearish technical indicators. The lack of positive valuation metrics further weighs on the stock's attractiveness.

Positive Factors

Revenue Growth

The company's strong revenue growth suggests a robust demand for its products and potential for market expansion, enhancing its competitive position.

FDA Approval

FDA approval of new products can significantly enhance market credibility and open new revenue streams, supporting long-term growth.

Strong Gross Margin

A strong gross margin indicates efficient production and pricing strategies, which can support profitability as the company scales.

Negative Factors

Profitability Challenges

Ongoing profitability issues may limit the company's ability to reinvest in growth and innovation, impacting long-term sustainability.

High Operating Losses

High operating losses can strain financial resources, potentially leading to liquidity issues and limiting strategic flexibility.

Increased Leverage

Increased leverage heightens financial risk and may constrain the company's ability to invest in growth opportunities or weather downturns.

Shoulder Innovations, Inc. Business Overview & Revenue Model

Company Description

Shoulder Innovations, Inc. (SI) is a medical technology company specializing in the development and commercialization of advanced orthopedic solutions specifically for shoulder surgeries. The company focuses on creating innovative surgical instruments and implants that improve patient outcomes and enhance surgical efficiency. Operating within the healthcare sector, SI aims to revolutionize shoulder surgery through its cutting-edge products that are designed for minimally invasive procedures.

How the Company Makes Money

Shoulder Innovations, Inc. generates revenue primarily through the sale of its orthopedic surgical products, including implants and instruments used in shoulder surgeries. The company utilizes a direct sales model, partnering with hospitals, surgical centers, and orthopedic surgeons to provide its products. Additionally, SI may engage in strategic partnerships with larger medical device companies to expand its distribution channels and market reach. Revenue is also supplemented through training programs for surgical staff and ongoing support services, ensuring that healthcare providers are well equipped to use SI's products effectively.

Shoulder Innovations, Inc. Financial Statement Overview

Summary

Shoulder Innovations, Inc. is experiencing revenue growth, but profitability and cash flow challenges persist. The company needs to address its high operating losses and improve cash flow management to enhance financial stability. The balance sheet shows increased leverage, which could be a risk if not carefully managed.

Income Statement

Shoulder Innovations, Inc. shows a significant increase in revenue from the previous year, indicating growth potential. However, the company is struggling with profitability, as evidenced by negative net profit and EBIT margins. The gross profit margin remains strong, but the high operating losses are concerning.

Balance Sheet

The company's debt-to-equity ratio has increased, suggesting a rise in leverage, which could pose a risk if not managed properly. The return on equity is negative, reflecting ongoing losses. However, the equity ratio indicates a reasonable level of equity financing relative to total assets.

Cash Flow

Cash flow from operations is negative, which is a concern for liquidity. The free cash flow to net income ratio is positive, indicating that the company is generating cash relative to its net losses, but the overall cash flow position is weak.

Breakdown	TTM	Dec 2024	Dec 2023
Income Statement
Total Revenue	10.13M	31.62M	19.27M
Gross Profit	7.79M	24.34M	15.27M
EBITDA	-3.63M	-12.76M	-9.52M
Net Income	-4.66M	-15.62M	-12.65M
Balance Sheet
Total Assets	57.52M	43.08M	54.29M
Cash, Cash Equivalents and Short-Term Investments	27.56M	15.04M	32.81M
Total Debt	14.77M	14.73M	14.46M
Total Liabilities	116.84M	22.33M	18.70M
Stockholders Equity	-59.31M	20.75M	35.59M
Cash Flow
Free Cash Flow	-7.32M	-18.16M	-15.89M
Operating Cash Flow	-6.48M	-14.14M	-13.14M
Investing Cash Flow	-13.07M	13.96M	-28.97M
Financing Cash Flow	19.79M	66.00K	44.73M

Shoulder Innovations, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MMSI	78 Outperform	$5.19B	45.21	8.30%	―	11.49%	-2.89%
LMAT	75 Outperform	$1.95B	41.90	15.02%	0.88%	13.07%	27.98%
VCEL	71 Outperform	$1.83B	290.70	4.52%	―	14.05%	241.86%
ATEC	58 Neutral	$2.94B	―	-540.40%	―	27.11%	17.66%
ICUI	57 Neutral	$3.10B	-82.51	-0.35%	―	-0.81%	93.27%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SI	41 Neutral	$224.98M	-7.01	―	―	39.77%	-122.70%

Shoulder Innovations, Inc. Corporate Events

Shoulder Innovations’ Clinical Study: A Game Changer for Shoulder Arthroplasty?

Shoulder Innovations, Inc. is conducting a study titled ‘Shoulder Innovations Clinical Data Registry’ to gather long-term clinical outcomes for anatomic and reverse total shoulder arthroplasty. This observational study aims to provide valuable insights into shoulder replacement procedures, which are crucial for improving patient care and advancing medical knowledge in this field.

Shoulder Innovations Reports Strong Revenue Growth Amid Losses

Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on revolutionizing the shoulder surgical care market with advanced implant systems for shoulder arthroplasty. In its second quarter of 2025, the company reported a 33% increase in net revenue, reaching $11 million, alongside a gross margin of 76.2%. The company also completed an IPO, raising $75 million, and closed a $40 million convertible notes financing. Key achievements include a 34% increase in implant system sales and the expansion of its I-Series humeral stem product line. Despite these successes, the company reported a net loss of $19.2 million, attributed mainly to changes in the fair value of its preferred stock warrant liability. Looking forward, Shoulder Innovations anticipates continued revenue growth, projecting a 33% to 39% increase for the full year 2025, supported by its strategic financial positioning and growing customer base.